Evidence map›Paper›PMID 36939249›Full record

ArticleJournal of visualized experiments : JoVE2023

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials.

Amita Sekar, Sashank Lekkala, Ebru Oral

Open access · bronzeAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Amita SekarHarris Orthopaedics Laboratory, Massachusetts General Hospital; Department of Orthopaedic Surgery, Harvard Medical School.
Sashank LekkalaHarris Orthopaedics Laboratory, Massachusetts General Hospital.
Ebru OralHarris Orthopaedics Laboratory, Massachusetts General Hospital; Department of Orthopaedic Surgery, Harvard Medical School; eoral@mgh.harvard.edu.
Massachusetts General Hospital · US

Funding

Drug-eluting joint implants with synergistic antimicrobial release and risk stratified models of preclinical efficacy testingR01AR077023 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI ORAL, EBRU · 2020 to 2024
$1.8M
NIAMS NIH HHS R01 AR077023
6 · The paper itself

Abstract

Ultrahigh molecular weight polyethylene (UHMWPE) is widely used in total joint arthroplasties as a load-bearing surface. Periprosthetic joint infections, the majority of which occur shortly after joint replacement, constitute almost 25% of total knee revision surgeries, and the complete eradication of bacterial infection poses a major challenge. A promising way to tackle this problem is to ensure the local sustained delivery of antibiotic concentrations sufficient to inhibit the bacteria to support routine systemic antibiotic prophylaxis. There is increased research into the development of efficient local drug delivery devices. Although established antibacterial testing methods for drugs can be used to test the antibacterial efficacy of drug-eluting materials, they are lacking in terms of providing real-time and longitudinal antibacterial efficacy data that can be correlated to the elution profiles of antibiotics from these devices. Here, we report a direct and versatile methodology to determine the antibacterial efficacy of antibiotic-eluting UHMWPE implants. This methodology can be used as a platform to avoid bacterial culture at each time point of a lengthy experiment and can also be adapted to other local drug delivery devices.

Indexed as

Bacterial InfectionsProsthesis-Related InfectionsAnti-Bacterial AgentsDrug Delivery SystemsHumansPolyethylenesAnti-Bacterial AgentsPolyethylenesultra-high molecular weight polyethylene

Identifiers

PMID36939249
PMCPMC10859037
OpenAlexW4323036891

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.